Fundraising Fox

Alixia

YC W22

San Francisco, US · Founded 2022 · Delaware corporation · 2 employees · 2 known investors

alixia.com ↗

Alixia develops therapeutics targeting tumor ecosystems to address cancer drug resistance and age-related diseases. The company integrates biology, biophysics, and computational chemistry to design compounds that disrupt metabolic and inflammatory triggers in multiple cell types within the tumor microenvironment.

BiotechDeep TechHealthtechMedical DevicesTherapeuticsDrug discoveryOncologyBiotechnologyin /alixia-therapeutics/@ycombinatorycombinator.com ↗

Founders & leadership· Y Combinator alumni (W22)

OMOlof Mollstedt
Olof MollstedtinFounder
HCHelen Chen
Helen CheninFounder
SL
Sungwon LimDirector

Investors · 2

Y CombinatorSan Francisco · $500K
ZAKA VCSan Francisco

Reported raises · per SEC filings

Form D private placements
▶$1.8MraisedJul 2024 · 19 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Sungwon LimDirector
  • Lars Olof MollstedtExecutive Officer, Director
  • Helen Yee-Fang ChenExecutive Officer, Director
Offering amount
$3.5M
Amount sold
$1.8M
First sale
Jul 2024
Incorporated
Corporation, Delaware, 2022
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.